Variation in IgE binding potencies of seven Artemisia species depending on content of major allergens
Authors:
Open Access
- 18 November 2020
- journal article
- research article
- Published by Wiley in Clinical and Translational Allergy
- Vol. 10 (1) , 1-13
Abstract
Background: Artemisia weed pollen allergy is important in the northern hemisphere. While over 350 species of this genus have been recorded, there has been no full investigation into whether different species may affect the allergen diagnosis and treatment. This study aimed to evaluate the variations in amino acid sequences and the content of major allergens, and how these affect specific IgE binding capacity in representative Artemisia species. Methods: Six representative Artemisia species from China and Artemisia vulgaris from Europe were used to determine allergen amino acid sequences by transcriptome, gene sequencing and mass spectrometry of the purified allergen component proteins. Sandwich ELISAs were developed and applied for Art v 1, Art v 2 and Art v 3 allergen quantification in different species. Aqueous pollen extracts and purified allergen components were used to assess IgE binding by ELISA and ImmunoCAP with mugwort allergic patient serum pools and individual sera from five areas in China. Results: The Art v 1 and Art v 2 homologous allergen sequences in the seven Artemisia species were highly conserved. Art v 3 type allergens in A. annua and A. sieversiana were more divergent compared to A. argyi and A. vulgaris. The allergen content of Art v 1 group in the seven extracts ranged from 3.4% to 7.1%, that of Art v 2 from 1.0% to 3.6%, and Art v 3 from 0.3% to 10.5%. The highest IgE binding potency for most Chinese Artemisia allergy patients was with A. annua pollen extract, followed by A. vulgaris and A. argyi, with A. sieversiana significantly lower. Natural Art v 1-3 isoallergens from different species have almost equivalent IgE binding capacity in Artemisia allergic patients from China. Conclusion and clinical relevance: There was high sequence similarity but different content of the three group allergens from different Artemisia species. Choice of Artemisia annua and A. argyi pollen source for diagnosis and immunotherapy is recommended in China.Keywords
Funding Information
- National Natural Science Foundation of China (31772271)
- International Science and Technology Cooperation Programme (2019YFE0106600)
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (ZYLX201826)
- OeAD-GmbH (CN 14/2020)
This publication has 29 references indexed in Scilit:
- Prevalence of sensitization to weed pollens of Humulus scandens, Artemisia vulgaris, and Ambrosia artemisiifolia in northern ChinaJournal of Zhejiang University-SCIENCE B, 2013
- The specific IgE reactivity pattern of weed pollen-induced allergic rhinitis patientsActa Oto-Laryngologica, 2010
- Mugwort-Sensitized Individuals from North Europe, South Europe and North America Show Different IgE Reactivity PatternsInternational Archives of Allergy and Immunology, 2010
- Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant SpeciesPLOS ONE, 2010
- Isoform identification and characterization of Art v 3, the lipid-transfer protein of mugwort pollenMolecular Immunology, 2009
- Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1Molecular Immunology, 2009
- Array‐based profiling of ragweed and mugwort pollen allergensAllergy, 2008
- Correlation of serum allergy (IgE) tests performed by different assay systemsJournal of Allergy and Clinical Immunology, 2008
- Phylogeny in Artemisia (Asteraceae, Anthemideae) inferred from nuclear ribosomal DNA (ITS) sequencesTaxon, 1999
- Mugwort and Sage (Artemisia) Pollen Cross-Reactivity: ELISA Inhibition and Immunoblot EvaluationAnnals of Allergy, Asthma & Immunology, 1997